Wolverine Trading, LLC Aurinia Pharmaceuticals Inc. Put Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$4.93 - $9.31 $234,175 - $442,225	-47,500 Reduced 68.54%	21,800 $109,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $494,109 - $657,657	69,300 New	69,300 $623,000
Q2 2023 Aug 23, 2023	BUY	$8.96 - $11.69 $344,960 - $450,065	38,500 Added 49.42%	116,400 $1.13 Million
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $375,408 - $712,264	63,200 Added 429.93%	77,900 $855,000
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $60,417 - $119,658	14,700 New	14,700 $64,000
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $967,494 - $1.38 Million	-108,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $204,015 - $456,344	20,300 Added 23.12%	108,100 $1.34 Million
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $412,496 - $767,456	-23,200 Reduced 20.9%	87,800 $2 Million
Q3 2021 Nov 12, 2021	BUY	$10.93 - $23.55 $1.21 Million - $2.61 Million	111,000 New	111,000 $2.55 Million

191

56.2M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.03B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.